News

London, United Kingdom – Rapid Nutrition PLC (OTCQB: RPNRF,), a natural healthcare company focused on sports nutrition, diet management and life sciences products with extensive worldwide distribution, is expanding its focus on the U.S. capital markets.

Building on its strong operational presence and significant distribution relationships throughout the United States, Rapid Nutrition recently commenced preparations for voluntary filing with the SEC to increase its visibility and outreach to U.S. investors, offering greater access to the U.S. capital market.

“The bulk of our company’s manufacturing and global fulfillment is already driven out of the United States and we aim to further emphasize the U.S. capital markets to drive shareholder value and increased liquidity for our global company,” said Rapid Nutrition CEO Simon St. Ledger. “Our U.S. growth has been significant over the past several years and this expanded focus is the next logical step in cementing our products, reputation and business throughout this key market.”

In addition, Rapid Nutrition is working towards up listing to the OTCQX top-tier market once all criteria are met and subject to OTC Markets approval, offering clear advantages for international companies, including Level 2 quotes for investors and eligibility for inclusion in the OTCQX Composite Index and other OTCQX indexes.

This year, Rapid Nutrition has also secured new distribution agreements in Brazil, France, Italy, Jamaica and Switzerland where the products are going through regulatory approval, as well as bolstering its direct to consumer e-commerce and Amazon channels, as more consumers recognize the importance of health, wellness and self-care products. The company aims to continue to grow its global distribution footprint throughout the European markets as well.

About Rapid Nutrition
Dedicated to the development and distribution of premium, science-based health and wellness brands across the globe, Rapid Nutrition shares a wealth of award-winning products with consumers who are passionate about innovations that are “made by nature, refined by science.” Rapid Nutrition’s first-class scientific team matches the experience of its management team to keep both the company and consumers on top of the latest industry trends and developments, while aligning with industry leaders worldwide to deliver effective supplements and solutions. Rapid Nutrition aims to be the supplier of choice globally by offering premium brands with the highest-quality ingredients to deliver maximum results.

For more information, please visit http://rnplc.com

Investor Relations Contact:
ir@rnplc.com

Forward-Looking Statements
This press release contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 that involve risks, uncertainties and assumptions that could cause Rapid Nutrition PLCs actual results and experience to differ materially from anticipated results and expectations expressed in these forward-looking statements. Rapid Nutrition PLC has in some cases identified forward-looking statements by using words such as "anticipates," "believes," "hopes," "estimates," "looks," "expects," "plans," "intends," "goal," "potential," "may," "suggest," and similar expressions. Rapid PLC undertakes no obligation to release publicly the results of any revisions to any such forward-looking statements that may be made to reflect events or circumstances after the date of this press release or to reflect the occurrence of unanticipated events, except as required by applicable law or regulation.

Disclosure Requirement:
This media information does not constitute an offer to sell, or a solicitation of an offer to buy, any securities. This information does not constitute an offering prospectus or a listing prospectus. The media release is in accordance with International Reporting Standard: Rule 12g3-2(b) under the Securities Exchange Act ('Rule 12g3-2(b)') permits non-U.S. companies with securities listed primarily on a Qualified Foreign Exchange to make publicly available to U.S investors in English the same information that is made publicly available in their home countries as an alternative to SEC reporting Exchange Act Rule 12g3-2(b).